On April 10, another session of the Cycle of Seminars “How small is the future?” is held.

Between 4:00 p.m. and 6:00 p.m., Helena F. Florindo, from the University of Lisbon, talks about the impact of nanotechnologies in medicine, from the example of the use of immunotherapy in the treatment of cancer. Participants in the session, as commentators, Tito Trindade and Iola Duarte, of the Department of Chemistry of the UA. The initiative, taking place in the amphitheater 5.2.22 of the Department of Education and Psychology, is open to the whole community.
Organized under the Nanotechnologies course of the Integrated Masters in Materials Engineering, this cycle integrates three thematic seminars on the impact of nanotechnologies on the future of society, from technological areas such as textiles and coatings, to health care.

Each seminar is moderated by an investigator or a technologist and aims to discuss the contribution that nanotechnologies can bring to development by addressing the potential benefits and risks that accompany them.

After each thematic talk given by an investigator, there will be a panel discussion. For each theme, the discussion will reflect issues associated with new nanotechnology solutions, such as scientific and technological impact, future scenarios, alternatives and state of the art in Portugal versus the rest of the world.

The discussion will be followed by a question and answer moment, during which all participants will have the opportunity to participate and get more information.

Scheduled Sessions:

  • Nanotechnology and Textiles,  March 20, 4:00 p.m. to 6:00 p.m.

Amphitheater 9.1.1 of the Department of Materials Engineering of Materials and Ceramic

Speaker: João Gomes, CENTI

  • Nanotechnology and Medicine, April 10, 4:00 p.m. to 6:00 p.m.


Speaker: Helena Florindo, University of Lisbon

Commentators: Tito Trindade and Iola Duarte, Department of Chemistry of the AU and CICECO – Institute of Materials of Aveiro


  • Nanotechnology and Coatings, May 8, 4:00 p.m. to 6:00 p.m.



Please follow and like us: